Latest filing published 28 Mar 2012 for DAXOR CORP, €669.
Insider track record
No signal scores available.
Closed purchases
Based on 17 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -16.8%Entry US$9.05 · Close at T+365 US$7.53
- -19.8%Entry US$9.35 · Close at T+365 US$7.50
- -22.0%Entry US$9.48 · Close at T+365 US$7.39
- -20.0%Entry US$9.27 · Close at T+365 US$7.42
- -21.9%Entry US$9.75 · Close at T+365 US$7.61
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Philip Nordan Hudson: trading record in brief
Philip Nordan Hudson is a declared insider of Daxor Corp, with filings sourced from SEC (Form 4). Between 15 February 2006 and 28 March 2012, the trades on record add up to 19 filings.
On the market, this insider has only ever bought: 18 purchases, €197k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 1 share grant. Since January 2012: 11 purchases and no sales on the market.
In size, the median ticket on the buying side is €3,150. Ninety days after publication, 17 purchases show a median change of -4.5%, with the price up in 12% of them. They describe history only and say nothing certain about the share price ahead.
On 28 March 2012 came the latest disclosure, an open-market purchase for €669 in Daxor Corp. Publication is fast: at least half of the trades appear on SEC (Form 4) on the same day. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Philip Nordan Hudson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 100 shares@ US$8.91Daxor Common StockSEC:0001019056-12-000416:0Canonical exit: 26 Jun 2012 (T+90)
- 205 shares@ US$9.15Daxor Common StockSEC:0001019056-12-000377:0Canonical exit: 19 Jun 2012 (T+90)
- 185 shares@ US$9.10Daxor Common StockSEC:0001019056-12-000377:1Canonical exit: 19 Jun 2012 (T+90)
- 315 shares@ US$9.10Daxor Common StockSEC:0001019056-12-000377:2Canonical exit: 19 Jun 2012 (T+90)
- 195 shares@ US$9.24Daxor Common StockSEC:0001019056-12-000368:0Canonical exit: 13 Jun 2012 (T+90)
- 100 shares@ US$9.23Daxor Common StockSEC:0001019056-12-000368:1Canonical exit: 13 Jun 2012 (T+90)
- 773 shares@ US$9.28Daxor Common StockSEC:0001019056-12-000355:0Canonical exit: 10 Jun 2012 (T+90)
- 227 shares@ US$9.26Daxor Common StockSEC:0001019056-12-000355:1Canonical exit: 10 Jun 2012 (T+90)
- 1,024 shares@ US$9.30Daxor Common StockSEC:0001019056-12-000062:0Canonical exit: 24 Apr 2012 (T+90)
- 976 shares@ US$9.15Daxor Common Stock (DXR)SEC:0001019056-12-000058:0Canonical exit: 23 Apr 2012 (T+90)
- 1,000 shares@ US$10.01Daxor Common StockSEC:0001019056-11-000495:0Canonical exit: 28 Jul 2011 (T+90)
- 100 shares@ US$10.00Daxor CorporationSEC:0001019056-11-000462:0Canonical exit: 20 Jul 2011 (T+90)
- 600 shares@ US$10.00(DXR) Daxor Common StockSEC:0001019056-11-000456:0Canonical exit: 19 Jul 2011 (T+90)
- 600 shares@ US$14.35DAXOR COMMON STOCKSEC:0001169232-06-004858:0
- 400 shares@ US$14.50Daxor Common StockSEC:0001169232-06-004569:0Canonical exit: 14 Feb 2007 (T+90)
- 3,500 shares@ US$18.53Common StockSEC:0001169232-06-000930:0Canonical exit: 16 May 2006 (T+90)
- 5,100 shares@ US$18.55Common StockSEC:0001169232-06-000930:1Canonical exit: 16 May 2006 (T+90)
- 1,100 shares@ US$18.50Common StockSEC:0001169232-06-000930:2Canonical exit: 16 May 2006 (T+90)
18 of 18 declarations